Among older adults, symptom number and burden stabilized and decreased in the year after dialysis
TUESDAY, Nov. 15, 2022 (HealthDay News) — For older adults with kidney failure, symptom burden worsens in the year before initiation of dialysis and stabilizes thereafter, according to a study published online Nov. 10 in the Clinical Journal of the American Society of Nephrology.
Esther N.M. de Rooij, M.D., from the Leiden University Medical Center in the Netherlands, and colleagues examined the course of total and individual symptom number and burden before and after starting dialysis in patients aged 65 years and older from the European Quality study with an incident estimated glomerular filtration rate ≤20 mL/min/1.73 m2. Thirty symptoms were assessed every six months between 2012 and 2021 using the dialysis symptom index (DSI). Data were included for 456 incident dialysis patients who completed at least one DSI in the year before or after dialysis.
The researchers found that symptom number increased +3.6 and symptom burden increased +13.3 in the year before dialysis initiation. In the year after, symptom number and burden decreased −0.9 and −5.9, respectively. The highest prevalence of symptoms was seen for “fatigue” (81 percent), “decreased interest in sex” (69 percent), and “difficulty becoming sexually aroused” (68 percent) at dialysis initiation, with burdens of 2.7, 2.4, and 2.3, respectively. After dialysis initiation, “fatigue” improved somewhat, while there was a further increase in the prevalence and burden of sexual symptoms.
“These results could help informing older patients with kidney failure who decided to start dialysis on what to expect regarding the development of their symptom burden,” the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk
Polypharmacy of Prescription Medications Increased for U.S. Older Adults
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
1997 to 2022 Saw Increase in Pediatric Hospitalizations With AKI